Imm announced the INSIGHT-003 trial has been expanded to four sites across Germany
So are they repeating the registration trial that Merck used to get Keytruda approved for NSCLC previously? If so why not make an
exact copy of the protocol Merck used with the same drugs to get approval so be oner?
Only a matter of time, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.015(4.41%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 33.5¢ | $1.213M | 3.471M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 1254253 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 252703 | 36 |
View Market Depth
| Last trade - 14.00pm 18/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |